{"name":"Biojiva LLC","slug":"biojiva-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RT001","genericName":"RT001","slug":"rt001","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"RT001","genericName":"RT001","slug":"rt001","phase":"phase_3","mechanism":"RT001 is a small molecule drug that targets the SGLT1 and SGLT2 transporters.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPd3pzRVBCcWRfR08xNkZKRkFpNEFNVld4dVBhb3V6U2lyN1RNOWRna0otYmFqZkEydlktZUFsZlF3VUlfSEJmVElZRUI0eXA2V2VyUzVrWlV4U3Bfb3hScGxmcnRhMVdMUXQ0UVVFa2twUENlYmVNLVVDUF9teW90ZXEzbHBSemNTZnl6YXBTbkliZGxOc3hodFUyMGxJX1FvQ1I3RXBzTnFFTzM0U21GUkUwUHNKTDcyVV9sYjc4T3hucXhzdnpBRWlDRFEwMllJWjFyenl3ekRkWUd2cllwVV9lMi16bUNMVFRfbnVTRmpEamx4OGJWWFBEMi1HLVVaZl9ZTnlJTm90cFlKaHY0UG52THd1QQ?oc=5","date":"2022-09-15","type":"trial","source":"GlobeNewswire","summary":"BioJiva Reports Results of Pilot Phase 2 Clinical Trial of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS) - GlobeNewswire","headline":"BioJiva Reports Results of Pilot Phase 2 Clinical Trial of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}